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The Role of Mannosyl-phosphoryl-dihydropolyisoprenol in 
the Synthesis of Mammalian Glycoproteins” 
(Eeceived for publication, March 21, 1973) 
JOHN W. BAYNES,~ AN-FEI Hsu, AND EDWARD C. HEATHS 
F1-om the Department of Physiological Chemistry, The Johns Hopkins Univedy School of Medicine, 
Baltimore, Maryland 21205, and the Department of Biochemistry, Univekty of Pittsburgh School of Medicine, 
Pittsburgh, Pennsylvania i 5261 
SUMMARY 
A mouse myeloma tumor was used as a model system to 
study the biochemical steps involved in the incorporation of 
mannose into glycoproteins. This tumor, MOPC-46B, 
synthesizes a K-type immunoglobulin light chain (K-46) 
which is a glycoprotein with a single oligosaccharide side 
chain containing mannose as one of its constituent sugars. 
MOPC-46B microsomal preparations contain enzymes 
which transfer mannose from the sugar nucleotide, GDP- 
mannose, to endogenous lipid and protein acceptors. Forma- 
tion of the mannolipid proceeds by the reversible transfer of 
mannose from GDP-mannose to an endogenous phospholipid. 
The mannolipid was purified and characterized by chemical 
methods and mass spectrometry as a mannosyl-monophos- 
phoryl-dihydropolyisoprenol, containing at least 18 isoprene 
units, one of which is saturated. 
The mannolipid was implicated as an intermediate in the 
in vitro mannosylation of endogenous protein acceptors by 
three kinds of experiments. (a) Incorporation of [l%]man- 
nose into protein was observed after the initial substrate, 
GDP-mannose, had been destroyed by sugar nucleotide 
hydrolases associated with the microsomal preparations. 
The continued increase in radioactivity in the protein fraction 
occurred concomitantly with a loss of radioactivity from the 
mannolipid fraction. (b) I ncorporation of [14C]mannose into 
both lipid and protein was inhibited by EDTA added at zero 
time. However, addition of EDTA after mannolipid syn- 
thesis had occurred resulted in cessation of mannolipid 
formation but continued incorporation of mannose into 
protein to an extent proportional to the amount of mannolipid 
originally formed. The increase in radioactivity in protein 
was again accompanied by a loss of radioactivity from the 
mannolipid. (c) When microsomes were pulsed briefly with 
GDP-[14C]mannose, which was then chased by a large excess 
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of unlabeled GDP-mannose, incorporation of [‘XZ]mannose 
into lipid ceased immediately with the chase, while incorpora- 
tion into protein continued afterwards to an extent propor- 
tional to the amount of mannolipid formed prior to the chase. 
Evidence that the mannolipid could function as a donor of 
mannose residues to protein was obtained by demonstrating 
that microsomes catalyze the transfer of [*4C]mannose from 
exogenously supplied mannolipid to endogenous protein 
acceptors. The amount of mannose transferred to protein 
was proportional to both microsomal protein and lipid concen- 
trations. In addition, the amount of mannose transferred 
to protein from exogenous mannolipid is comparable to that 
incorporated from an equivalent amount of mannolipid 
generated endogenously from GDP-mannose. 
Gel filtration profiles of the [14C]mannose-containing 
protein formed in this system are essentially identical regard- 
less of whether GDP-mannose or mannolipid is used as 
substrate. In both cases the radioactive protein fractionates 
in a manner similar to authentic K-46 (mol wt 24,000). The 
mannose-containing protein formed from either GDP- 
mannose or mannolipid was degraded sequentially by Pro- 
nase and subtilisin. The products formed from either 
substrate appeared to be identical and exhibited chromato- 
graphic and electrophoretic characteristics of glycopeptides. 
It was concluded that mammalian microsomal preparations 
contain an endogenous phospholipid, characterized as a 
dihydropolyisoprenol-monophosphate, which serves as an 
acceptor of mannose from GDP-mannose, resulting in the 
formation of mannosyl-monophosphoryl-dihydropolyisopre- 
nol, and that this mannolipid serves as a glycosyl donor for 
transfer of mannose residues to endogenous protein ac- 
ceptors. The evidence indicates that the mannolipid is an 
essential intermediate in the in vitro transfer of mannose 
from GDP-mannose to protein. 
The predominant type of glycoprotein in plasma contains car- 
bohydrate linked by an N-glycosyl bond between a reducing 
terminal N-acetylglucosamine in the oligosaccharide and an as- 
paragine residue in the polypeptide chain. The oligosaccharide 


























containing mannose and N-acetylglucosamine and an external 
region containing galactose, fucose, sialic acid, and additional 
N-acetylglucosamine residues (2, 3). 
The biosynthesis of the external region proceeds by addition of 
single sugar residues to a growing oligosaccharide side chain. 
The sequential addition of external N-acetylglucosamine, galac- 
tose, sialic acid, and fucose residues by transferases of the endo- 
plasmic reticulum and Golgi apparatus has been accomplished 
using exogenous protein acceptors, generally prepared by treat- 
ment of native glycoproteins with the appropriate glycosidase(s) 
(2-5). Investigations on the mode of addition of the mannose 
residues in the core region, however, have been hampered by an 
inability to prepare efficient exogenous acceptors by glycosidase 
treatments, or to find native proteins which can function as arti- 
ficial acceptors. Therefore, it has become necessary to study 
mamlosyltransferase reactions using endogenous acceptors con- 
tained in the transferase preparations (6-8). These studies are 
frequently complicated by the low levels of endogenous acceptors 
in cells and their heterogeneity with respect to both the polypep- 
tide chains and the nature of the oligosaccharide side chains. 
Some of these difficulties may be minimized in a system that 
produces a single mannose-containing glycoprotein with one 
oligosaccharide side chain of defined structure. We have there- 
fore selected a mouse myeloma tumor, MOPC-46B, as a model 
system to study the addition of mannose residues to glycopro- 
teins, and to investigate specifically the possible role of lipid in- 
termediates in this process. 
been detected in a number of mammalian cell types, and they 
have been implicated as intermediates in the transfer of mannose 
from GDP-mannose to glycoproteins, in general (S), and to 
secreted proteins, in particular (17). However, direct charac- 
terization of the mannolipids and conclusive identification of tri- 
chloroacetic acid-insoluble products as glycoproteins have not 
been previously reported. In the present study we establish the 
identity of the mannolipid and the glycoprotein nature of the 
trichloroacetic acid-insoluble product, and demonstrate by indi- 
rect and direct methods that the mannolipid is an intermediate 
in the in vitro mannosylation of endogenous, microsomal protein. 
EXPERIMENTAL PROCEDURE 
Materials 
The plasma cell tumor, MOPC-4613, synthesizes a K type irn- 
munoglobulin light chain, which is a glycoprotein (mol wt - 
24,000) with a single serum type oligosaccharide side chain at- 
tached at asparagine residue 34 in the peptide chain (9-11). 
The oligosaccharide contains 4 mannose residues in addition to 
3 N-acctylglucosamine, 4 galactose, 2 fucose, and 2 sialic acid 
residues. The synthesis of K-46l accounts for 35 to 4Ocj, of the 
total protein synthesis by MOPC-461~ cells in suspension in vitro, 
as measured by relative rates of incorporation of [3H]leucine into 
immunoprecipitable and total trichloroacetic acid-precipitable 
protein (10, 12). In addition, similar studies using [l-3H]galac- 
tose and [l-3H]mannose indicate that K-46 represents at least 
50% of the total glycoprotein synthesis by the myeloma tumor 
(12). Thus, the MOPC-46B tumor is highly directed for syn- 
thesis of a single species of glycoprotein coiitaining a single type 
of oligosaccharide side chain. 
Plasma cell tumor, MOPC-4613, was obtained from Dr. Mi- 
chael Potter, National Institutes of Health, and was maintained 
by serial transplantation in Balb/c mice. The tumors used were 
generation numbers 71 to 92 and were used 3 to, 4 weeks after 
subcutaneous transplantation. GDP-[ U-V]mannose (152 mCi 
per mM) and [3H]GDP (2 Ci per InM) were obtained from New 
England Nuclear Corp. Nonradioactive sugars, nucleotides, and 
their derivatives, and the enzymes Pronase, subtilisin, and al- 
kaline phosphatase were obtained from Sigma. Triton X-100 
used in incubation mixtures and all reagents for radioactivity 
measurements were obtained from Packard Instruments. The 
DEAE-cellulose used was Whatman DE-52 (H. Reeve Angel and 
Co.). Sephadex G-50, G-150, LH-20, and LH-60 were obtained 
from Pharmacia Fine Chemicals, Inc. Bio-Gel P-2 and Dowex 
l-X8 were obtained from Bio-Rad. Unisil activated silicic acid 
was obtained from Clarkson Chemical Co., Inr. Adsorbeilts for 
thin layer chromatography were purchased from E. 1Ierck. 
Organic solvents used in purification of lipid were reagent grade, 
freshly redistilled, and contained 0.01 y0 butylated hydrosy- 
toluene as antioxidant. 
Radioactivity Xeasurenaents 
Quantitative determinations of radioactivity were obtained on 
a Packard liquid scintillation spectrometer, model 4322. Lipid 
and aqueous samples were counted in a scintillation fluid con- 
sisting of toluene:Triton X-100 (2:l) containing 5.5 g per liter 
of 2,5diphenyloxazole and 125 mg per liter of 1 ,4-bis[2-(4. 
methyl-5-phengloxazolyl)]benzene. Particulate pamplrs were 
solubilized in hydroxide of Hyamine 10X and counted in tolucne 
containing 4.0 g per liter of 2,5~diphenyloxazolc and 100 mg per 
liter of 1,4-bis[2-(5-phcnylosazolyl)]benzene. 
The role of polyisoprenol phosphates as glycosyl acceptors 
which mediate the transfer of sugars from sugar nucleotides to 
polysaccharides has been clearly established in prokaryotic sys- 
tems (13). The widespread occurrence of similar polyisoprenoid 
lipids in eukaryotic systems has led to intensive investigation of 
their role in the synthesis of polysaccharides in yeast and plant 
systems, and of glgcoproteins in mammalian systems (14). The 
demonstration that mammalian glycoproteins are glycosylated 
by membrane-associated enzymes (2-5), that the acceptor glyco- 
proteins are intimately associated with the intracellular mem- 
brane fractions (2-8, II), and that these membranes contain 
polyisoprenol phosphate (14-16) which can function in vitro as 
glycosyl acceptors (8, 16) has stirnulated a number of investiga- 
tions using various sugars (N-acetylglucosamine, glucose, galac- 
tose, and rnannose) and lipids (dolichols and vitamins h and K) 
in order to evaluate the possible role of glycolipids in the biosyn- 
thesis of glycoproteins (14). ~~aniiose-acceptil~g lipids have 
Analytical Methods 
Protein was determined by the method of Lo\\-ry et al. (18), as 
modified by Miller (19), using bovine serum albumin as standard. 
Lipid phosphate was determined according to l’artlett (20), as 
modified by Dittmer and Wells (al), and reducing sugar by the 
m&hod of Park and Johnson (22). 
Preparation oj Xicrosomal Fraction 
Small tumors (2 to 3 g) were excised and washed with ice-cold 
homogenizing buffer (0.05 M Tris-maleate, pH 7.4, containing 
0.25 M sucrose). All subsequent procedures were carried out at 
O-4”. Necrotic tissue was removed, and the tumor was minced 
and susl)ended in 2>$ volumes of buffer. The suspension was 
1 The abbreviations used are : K-46, the +immlmoglobldin homogenized with 6 to 10 strokes of a motor-driven glxs+Teflon 
K-type light chain synthesized by the MOPCIBB mouse myeloma Potter-Elvehjcm homogenizer. The crude homogenate was cen- 


























in the SS-34 rotor. The supernatant fluid was decanted, and 
the microsomal fraction was sedimented by centrifugation for 2 
hours at 78,000 x g in the Beckman No. 30 rotor. The crude 
microsomal pellet was resuspended in homogenizing buffer at a 
protein concentration of 20 to 40 mg per ml. Enzymatic ac- 
tivity for transfer of mannose from GDP-mannose to lipid was 
stable to freezing for several months. The activity for transfer 
of mannose from GDP-mannose to protein was unstable, and 
preparations morethan 1 week old were not used for that purpose. 
Assay Procedures 
Incorporation of Mannose into Lipid and Protein 
Standard assay mixtures were incubated in 3-ml test tubes at 
room temperature in the homogenizing buffer containing 1 to 100 
pM GDP-[‘*C]mannose (25,000 to 200,000 cpm), 5 mM MnCl?, 
5 mM M&12, and 0.6 to 3 mg of microsomal protein in a final vol- 
ume of 100 ~1; larger incubation mixtures were scaled-up propor- 
tionately. Reactions were quenched by addition of 3 volumes 
of a solution containing 2 parts of I-butanol-1 part of 6 M pyri- 
dinium-acetate, pH 4.2, and then vortexed. The incubations 
were then centrifuged for 3 to 5 min at maximum speed in the 
No. 809 head of an International model CL clinical centrifuge. 
A distinct aqueous phase and proteinaceous interface is observed 
from assay mixtures at low protein concentration, but at higher 
protein concentrations the aqueous phase is occluded within a 
proteinaceous pellet. The upper (organic) phase was removed 
nearly quantitatively with a 500.~1 syringe (Hamilton model No. 
1750 N). A second extraction was performed with an additional 
200 ~1 of I-butanol, and the combined organic extracts were 
washed with 500 ~1 of HZO. An aliquot of the organic phase n-as 
dried at 70” in a scintillation vial and counted in toluene-Triton 
X-100 scintillation fluid for estimation of mannolipid formed. 
The lipid-free protein pellet was dispersed and partially solubil- 
ized in 0.5 ml of 0.5 M NaOH by sonication for 10 s at minimum 
power using the micro tip attachment of a Heat Syst.ems-Ultra- 
sonics model W185 sonifier-cell disruptor. Protein was reprecip- 
itated by 235 ml of lOy0 trichloroacetic acid and collected by 
centrifugation. This procedure was repeated, and the pellet was 
finally washed with sonication in 2 ml of 80% ethanol. The 
protein pellet was dispersed in 100 ~1 of methanol, solubilized in 
1 ml of Hyamine hydroxide 10X, and counted in 10 ml of toluene 
scintillation fluid for determination of mannose incorporated into 
protein. 
Transfer of Xannose from Lipid to Protein 
Organic Solvent Extraction of Microsomal Protein-Microsomal 
pellets were resuspended by gentle homogenization in 3 volumes 
of HzO, and 2-ml aliquots were frozen in a thin shell, lyophilized, 
and then extracted for 1 hour at 0” with 10 ml of I-butanol. The 
delipidated protein was collected by centrifuging for 15 min at 
10,000 x g, and residual butanol was removed from the pellet 
by lyophilization. The delipidated protein was then resuspended 
in homogenizing buffer so that I ml corresponded to 2 g of original 
tumor. The enzymatic activity for transfer of mannose from 
lipid to protein was stable for several weeks upon freezing at 
-20”. 
Partial Purijkzation of JZannolipid-[14C]l\lannose-labeled lipid 
was extracted from muuse liver microsomes with butanol-pyri- 
dinium a&ate, deacylated as described below, and applied in 
CHCl, solution to a small column of DEAE-cellulose prepared in 
99% CH,OH according to Rouser (23) and equilibrated wit’h 
CHCla. The column was washed in succession with 2 volumes 
of 99y0 CHaOH, 2 volumes of CHCla-acetic acid (3 :I), and 2 
volumes of 99% CHSOH. The mannolipid was then eluted with 
2 volumes of 99% CHSOH containing 0.2 M NH&, concentrated 
by flash evaporation, dissolved in CHC13-CH80H (2:1), and 
washed by partitioning against 0.2 volumes of I-120 as described 
by Folch (24). This lipid was stored in CHC15 and ITas stable 
to storage at -20” for at least 2 months. 
Standard Incubation-Partially purified [14C]mannolipid was 
added in CHCl, (50 to 100 ~1) to 50 ~1 of homogenizing buffer 
containing 1% Triton X-100, 10 m1\z MnCls, and 10 rnM I!lgCl~. 
The CHCls phase was removed under a stream of dry nitrogen. 
Aliquots of fresh or delipidated microsomal protein suspensions 
(1 to 3 mg of protein) were added with buffer to bring the final 
volume to 100 ~1, and the mixture was incubated at roorn tem- 
perature, and quenched and processed as described above. 
Proteolytic Digestion of Mannose-containing Protein 
The 14C-labeled protein products were dispersed by sonication 
in 1 ml of 10 M urea per 20 to 30 mg of protein, and diluted with 
1 volume of 0.05 M Tris-Cl, pH 7.8, containing 1.5 rnM CaCl2. 
Pronase was added (1% of protein by weight) and digestion was 
carried out at 30”. After 18 hours the mixture was heatrd for I 
min at loo“, sonicated for 10 s, and a second portion of I’ronase 
was added. After an additional 18 hours, the mixture was again 
heated and sonicated, then adjusted to 10 m&l EDTA, 1% mer- 
captoethanol. Subtilisin (1% of protein by weight) was added, 
and digestion was continued for an additional 24 hours at 30”. 
At the end of this time solid sodium dodecyl sulfate was added 
to a final concentration of 2%. The proteolytic digest was chro- 
matographed on a column (1 x 40 cm) of Sephades G-150 in 
1% sodium dodccyl sulfate, 1 y0 2-mercaptocthanol, 0.1 BI EDTA, 
0.05 M sodium phosphate, pH 8.0. The low molecular weight 
products of the proteolytic digestion were collected from the re- 
tention volume of the Sephadcx G-150 column, the sodium do- 
decyl sulfate was rernoved on a column of Dowcs l-X8 (chloride 
form) according to Weber and Kutrr (25), and urea and salts 
were rcrnovcd by chromatography 011 Hio-Gel 1’.2 in H20. Re- 
covery of a radioactivity from the Dow-es 1-X8 and 13io-Gel P-2 
columns was greater than 957,, and essentially all of the radio- 
activity is recovered at the exclusion volume on the Isio-Gel P-2 
column. 
Purification of Bovine Liver Xannolipid 
Bovine liver (6.5 kg) was homogenized in a JYaring IUendor 
in 2;s volumes of homogenizing medium, filtered through two 
layers of cheesecloth, and centrifuged at 1,500 x g for 30 min 
in a Scrvall GS-3 rotor to remove whole cells and debris. The 
supernatant was decanted, adjusted to pI-I 4.9 with 1 42 acletic 
acid, and recentrifuged at 10,000 X g for 30 min. The pellet 
was resuspended to 9 liters with homogenizing medium contain- 
ing 5 mM MgCl, and 5 mM MnCl,, and incubated in 1 to 2 liter 
volumes with 4 pM GDl’-[14C]mannose (1 PC1 per PL~\I) for I5 min 
at room temperature and quenched by addition of 1 volume of 
butanol-pyridinium acetate. The organic phase was separated 
by ccntrifugation for 5 min at 2,000 x g in an International 
model PR-2 refrigerated centrifuge using the lu’o. 253 head. The 
organic phase was removed and the aqueous phase and interface 
were re-extracted with an additional volume of I-butanol. ‘I’hc 
organic phases were combined, washed with an equal volume of 
H?O, concentrated to near dryness on a rotary evaporator at 25”, 
and dissolved in 1 liter of CHCl,-CH,OH (1: 1). The manno- 
lipid was precipitated by addition of 5 volumes of acetone at O”, 


























in 1 liter of toluene-CHsOH (1: l), and deacylated by mild alka- 
line methanolysis (0.1 1\~ KOH) for 5 min at room temperature 
according to the method of White and Frerman (26) ; this pro- 
cedure was repeated three times. The lipid was dissolved in 1 
liter of CHCls and applied to a 400-ml column of silicic acid. 
The column was washed with 2 liters of CHC13, then the manno- 
lipid was eluted with 2 liters of 99% CH,OH. The eluant was 
applied to a column of DEAE-cellulose (4 x 22 cm) prepared 
according to Rouser (23). The column was washed in succession 
with 1 liter of 99% CH,OH, 1 liter of CHCla-acetic acid (3:1), 
1 liter of 99% CHsOH, and eluted with a linear gradient of 0 to 
0.2 sr XI-I&c (pH 4) in 99% CHBOH (27). The mannolipid was 
eluted quantitatively as a symmetrical peak of radioactivity at 
0.05 M NH4Ac. The DEAE-cellulose column was washed with 
99% CHsOH to remove salt, and the pooled Folch-washed lipid 
was reapplied to the same column in CHCl&HsOH-concen- 
trated NH,OH (40 :20:1), and eluted with a linear gradient of 
0 to 0.025 M NH4Ac (23). More than 95y0 of the radioactivity 
was eluted as a single symmetrical peak at 0.005 M NH4Ac. The 
pooled lipid was concentrated and applied to a column of Sepha- 
des LH-20 (0.8 x 40 cm), and eluted with CHCI&HaOH (1 :l), 
again yielding a single symmetrical peak of radioactivity. Pre- 
parative thin layer chromatography was performed on Silica Gel 
G in CI-ICI,-CH,OH-Hz0 (12:6: 1). Rhodamine 6G staining 
revealed three components with RF values of 0.2, 0.4, and 1.0, 
respectively. All of the radioactivity was found in the band at 
RF 0.4. The mannolipid was eluted from the Silica Gel G with 
CHC1&H30H-Hz0 (1 :l:O.l), and saponified for 30 min at 
70” under nitrogen in 60% aqueous KOH-absolute ethanol (1:5, 
v/v). The resulting nonradioactive lipid was extracted by 
addition of Hz0 and n-hexane. Analytical thin layer chroma- 
tography revealed a single component with an RF of 1.0 in 
CHCls-CHZOI-I-H20 (12 :6: I). On development of the chro- 
matogram in a second dimension with CHCl,, about 90% of the 
iodine staining material chromatographed as a single component 
with an RF 0.7. 
Chromatography and Electrophoresis 
Descending paper chromatography was carried out on What- 
man xo. 1 paper, using the following solvent systems: A, 
isobutyric acid-concentrated NHJOH-Hz0 (57 : 4 : 39) ; and B, l- 
butanol-pyridine-HtO (9 : 5 :4). Paper electrophoresis was per- 
formed on Whatman No. 3MM paper using buffer systems: C, 
1% sodium borate; D, 58 ml of 88% formic acid and 156 ml of 
glacial acetic acid diluted with 1~20 to 2 liters (pH 1.85) ; and 
E, 25.5 g of sodium bartital and 3.3 g of barbituric acid diluted 
with Hz0 to 2 liters (pH 8.7). Unlabeled standard sugars and 
their derivatives were located with aIkaline silver nitrate (28) 
after treatment of the paper with 5 mM periodic acid in acetone. 
Radioactivity was located by scanning paper strips on a Packard 
radiochromatogram scanner, model 7201. Quantitation of ra- 
dioactivity was accomplished by cutting the paper strips into 
l-cm pieces and counting them in a vial containing 20% aqueous 
toluene-Triton X-100 scintillation fluid. 
Thin layer chromatography was performed on Silica Gel G in 
solvent systems: F, CHC&CHaOH-Hz0 (12 : 6 : 1) ; G, CHCl,- 
CI-130H-HO&H20 (25 : 15 :4 :2) ; and II, CHC1&H30H3-con- 
centrated NH40H (75 :25:4) ; and on alumina in solvent system 
J, CHCIZ-ethanol-70 mM ammonium acetate (18 :25:7) (29). 
Lipids were located on chromatograms by staining with either 
iodine vapor or rhodamine 6G. Radioactivity was located and 
quantitated by scraping l-cm cuts into scintillation vials con- 
MINUTES 
FIG. 1. Incorporation of mannose into lipid and protein. A 
large incubation mixture (2 ml final volume) contained 4 UM GDP- 
mannose (100,000 cpm) with 1.2 mg of protein per loo-pi aliquot. 
Protein and lipid were measured from loo-p1 aliquots as described 
under “Experiment,al Procedure.” Note the expansion of the 
cpm lipid scale at 4000 cpm. This is done to permit comparison 
of the relative kinetics and extent of loss of [14C]mannose from 
the lipid fraction with the gain of [14C]mannose in the protein 
fraction. 
taining 207, aqueous toluene-Triton X-100 scintillation fluid for 
counting. 
RESULTS 
Synthesis and Characterization of Mannolipid 
Formation of Mannolipid-In preliminary studies it was ob- 
served that incubation of microsomal protein, isolated either 
from the myeloma tumor or from murine or bovine liver, with 
GDP-[‘%]mannose resulted in an initial burst of mannose in- 
corporation into a lipid fraction during the first 5 min, accom- 
panied by a decreased rate and extent of mannose incorporation 
in protein over a 2-hour period (Fig. I). Further studies revealed 
that incorporation into lipid is linear for about 5 min at 100 pM 
GDP-mannose, but reaches a maximum rapidly at lower sub- 
strate concentrations because of substrate destruction presuma- 
bly catalyzed by sugar nucleotide hydrolases in the microsomal 
preparations; the hydrolysis of GDP-mannose results in a transi- 
ent production of a small amount of mannose-l-P, but after 3 
min incubation in the presence of 4 pM GDP-mannose only man- 
nose is detectable in the 80% ethanol extract of the incubation 
mixture. The microsomal preparations are rich in both sugar 
nucleotide hydrolase activity and phosphatase activities, but 
these enzymes were neither quantitated nor further characterized. 
The half-maximal rate of lipid formation is attained at about 
0.7 pM GDP-mannose and requires 5 mM divalent cation for 
maximal activity, but it exhibits no special preference for either 
MnZ+ or Mg2+. The reaction is greater than 95% inhibited by 
2.5 mM EDTA. Stimulation by Triton X-100 is variable; levels 
up to 0.5y0 are not inhibitory and frequently result in up to l-fold 
stimulation of mannolipid formation. Additions of 2-mercapto- 
ethanol, glutathione, or KF had no significant, reproducible ef- 
fect on mannolipid formation. 
Reversibility ojMannolipid Formation-Mannose incorporation 
into lipid reaches a maximum within 3 min at an initial concen- 
tration of 2 pM GDP-mannose (Fig. 2). Addition of excess GDP 
at 3 min results in a rapid loss of [%]mannose from the lipid frac- 
tion; the degree of displacement is dependent on the amount of 
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FIG. 2. Reversibility of mannolipid formation. li:ach poi& 
represents a separate loo-p1 incubation containing I mg of micro- 
somal protein and 2 PM GDP-mannose (50,000 cpm). At 3 min, 
10 ~1 of buffer were added to the controls, and 10 ~1 of 1 mM GMP, 
GDP, or GDP-mannose were added to other incubations. 
not shown). This loss is not observed upon addition of com- 
parable quant.ities of either G>IP or unlabeled GDP-mannose. 
When unlabeled GDP-mannose (4 pM) was used as substrate for 
an incubation mixture, then followed by a loo-fold excess of 
[3H]GDP and quenched rapidly (10 s), [3H]GDP-mannose could 
be identified as a reaction product by chromatography in Solvent 
System A. These results are in agreement with those observed 
in the pig liver system (8) and indicate that the mannolipid is 
formed by a reversible transfer of mannose to the acceptor lipid 
with concomitant formation of GDP as a product, as shown 
below : 
GDP-mannose + acceptor lipid ti mannolipid + GDP 
According to this scheme dilution of the specific activity of the 
GDl’-[14C]mannose by addition of an excess of unlabeled GDP- 
mannose (at 3 min in Fig. 2) should also cause a dilution of 
radioactivity in the lipid by an exchange reaction. Richards 
and Hemming (8) have demonstrated this equilibrium between 
GDP-mannose and mannolipid in the pig liver system, but, from 
the results in Fig. 2, (cf. also Fig. 6), it is clear that the equilibra- 
tion is not readily demonstrated in the myeloma tumor system. 
The failure of unlabeled GDP-mannose to dilute the lipid radio- 
activity in these experiments may result from the rapid destruc- 
tion of GDP in these incubations, such that the reverse reaction 
in the proposed exchange reaction is prevented. 
Spec$city of Mannose Transfer to Lipid--The incorporation of 
[14C]mannose into the lipid appears to be relatively specific (Fig. 
3) in that addition of large excesses of other unlabeled sugar 
nucleotides does not significantly interfere with the total incorpo- 
ration of mannose into lipid. GDP-glucose is the only nucleotide 
that inhibits incorporation of mannose into lipid, but it is possible 
that its degradation products, GDP and GMP, are responsible 
for this inhibition. The small degree of stimulation observed 
with the other nucleotides could result from protection of the 
GDP-mannose from the microsomal hydrolases. The insensi- 
tivity of the mannosyltransferase to UDP-glucose is at variance 
with results reported for the pig liver system (8). Glucose is, 
in fact, transferred from UDP-glucose to a lipid in the myeloma 
CONTROL . 
I 5 IO 
MINUTES 
FIG. 3. Specificity of mannose transfer to endogenous acceptor 
lipid. Standard incubation mixtures (total volume SO0 ~1) con- 
tained 4 PM GDP-mannose (100,000 cpm) and 1 mM competing 
nucleotide. Aliquots of 100 ~1 containing 0.6 mg of protein were 
withdrawn for determination of mannolipid. 
J 
MINUTES 
FIG. 4. Acid and base hydrolysis of crude myeloma tumor 
mannolipid. Acid hydrolysis : 25,000 cpm of crude lipid dissolved 
in 5 ml of CHCl&H,OH (2:l) containing 0.05 ml of 10 N HCl, 
maintained at 17” in a water bath. At specified times 0.5.ml ali- 
quots were neutralized with 0.1 ml of 0.5 N NaOH, vortexed, and 
centrifuged. An aliquot of the lower (organic) phase n-as re- 
moved, dried, and counted in toluene-Triton X-100 scintillation 
fluid. Base hydrolysis: 25,000 cpm of crude lipid dissolved in 4.5 
ml of absolute ethanol and 0.5 ml of 1 N NaOH, maintained at 
100” in boiling water bath. Aliquots of 0.5 ml were placed in ice, 
neutralized with 0.05 ml of 1 N HCl, and partitioned into two 
phases by addition of 0.8 ml of CHC13 and 0.15 ml of H?O. The 
lower phases were counted as above. 
tumor microsomes, as reported for the pig liver system, and this 
lipid is indistinguishable from the mamlolipid on thin layer 
chromatography in Solvent Systems F, G, and II. The reason 
for the differences in the competitive interaction between GDP- 
mannose and UDP-glucose in the liver and myeloma tumor sys- 
tems remains to be established. 

























resulted in quantitative rrlease of radioactivity into the aqueous 
phase following Folch partitioning against I&O (24). On treat- 
ment of’ the [‘4C]Ixalliiose-labeled lipid with 0.01 s IICl for 2 min 
at 100” ill 50% I-propanol, the radioactivity is recovered quanti- 
tatively in the aqueous phase as [‘4C]mannose (identified by 
chromatography in Solvent System U). No other radioactive 
compoul~cl was detectable. In 0.1 x HCl in CHCl,CH,OH 
(2:l) at 17” the mannolipid has a half-life of 15 min, and the 
products in the aqueous phase were identified as mamlose and 
methyl-mannoside (chromatography in Solvent System A and 
electrophoresis in 1% sodium borate). In 0.1 s NaOH in 90% 
ethanol at IOO”, the mamiolipid has a half-life of 1.5 min, and 
the product in the aqueous phase was identified as rnannose-1-I’ 
(chromatography in Solvent System A and elect’rophoresis in 1 y0 
sodium borate). Hased on the kinetics of hydrolysis of the lipid 
in both acid and base and the nature of the water-soluble prod- 
ucts, it was concluded that the mamlosc was linked by a glycoside 
bond to the lipid moiety through a phosphate or pyrophosphatc 
bond. 
Ckaracferization 01 Xannolipid-The [14C]maniwlil)ids formed 
with either the myeloma tumor or bovine liver systems were in- 
distinguishable and both appeared to be single species by several 
criteria. (n) *-1 single band of radioactivity was located on 
analytical thin layer chromatography on Silica Gel G in Solvent 
Systems F (RF = 0.6), G (RF = 0.95), and H (RF = 0.35), and 
on alumina in Solvent System J (RF = 0.2). (b) During prepara- 
tivc isolation of the lipid (see “Experimental Procedure”) a single 
peak of radioactivity \vas obtained from a column of DEAE- 
cellulose cluted xvith a gradient of 0 to 0.2 M NH&c, 111-I 4, in 
99% CI-1,01-I (elution at 0.05 M salt), or a gradient of 0 to 0.025 M 
NHIA\c in CI-IC113-CI180H-colIcclltratcd NII,OT-I (40 : 10 : 1) (elu- 
tion at 0.005 M salt). (c) A single peak of radioactivity was 
obtained on elution from Sephades LH-20 and LI-I-60 in three 
diffcrcwt solvents: C’HC13, 99 y0 CI1,01-I, and CHCl&HBOH 
(1 :l). (d) The kinetics and estent of acid and base hydrolysis 
of the malulolipid in crude extracts were consistent with the 
esistenw of a single species of lipid. 
In order to obtain sufficient quantity for structural studies, 
tile rnalmolipid was purified from bovine liver microsomes by 
standard fractionation tcchniqucs (see “Esl~crimental Pro- 
ccdure”), and the phospl~orus to sugar ratio in the lipid was used 
as an intlt,.\; of purification (Table I). The final product, 
20,000-fold purified over the crude estract, exhibited an organic 
phosl~horus to acid-labile reducing sugar ratio of 1.2. This 
product uxs hon~ogrneous in terms of the distribution of radio- 
activity and iodine staining on thin layer chromatography on 
Silica Gel G in Solvent S . t 1 s ems F, G, and I-I. The discrepancy 
bctwwl the quantity of mannose in the lipid determined by 
specific radioactivity of the GDP[Wlmannose and that deter- 
mined by reducing sugar assay following mild acid hydrolysis 
probably- reflects the prescncc of a low level of endogenous man- 
nolipid ilr thr microsomal preparation. In the experiment out- 
lined in ‘1’ablr I, a 33ci, loss of lipid occurred in the 1)urification 
n-hen the lipid was csposc~l to acidic conditions during concen- 
tration of’ fractions from the first I>EAE-cellulose column. This 
n-as a handling error, and in subsequent isolations, the over-all 
recovery at t’hc stage prior to thin layer chromatography was 
improwd to better than 90(;;,. Recovery of the radioactive lipid 
from the single radioactive band obtained on thin layer chromato- 
grams rarely csccedrd 60yc; this loss resulted frorn both irrc- 
wrsiblc adsorption of the lipid to silica gel, and partial degrada- 
tion of a fraction of the lipid to water-soluble forms. 
‘1’h(l ultraviolet spectrum of the purified mannolipid (0.1 mM 
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DEA@-eluate. 
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1.4 x 105 8 x 10” 
8.6 x 104 5.7 x 104 
1.2 x 103 800 
15 1 19 
0.3(1.1)c1 1.4 1 3.5(1.2)~ 
a See “Experimental Procedure” for details. 
b From specific activity of CTI>P-[14C]mannose (1 &i per pmole). 
c Redllcing sllgar estimated after acid hydrolysis by the method 
of Park and Johnson (22). 
organic phosphate in n-hesane using the Cary 14 recording 
spectrophotometer) was compared to the spectra of vitamin A 
acetate and vitamin K (melladione) at similar concentrations. 
The absorption of both the mannolipid and the free lipid (pre- 
pared by base hydrolysis) was llcgligible and featureless in the 
300 to 400 nm range. There is no indication that the mannolipid 
from bovine liver contains a conjugated carotenoid (vitamin A) 
or ubiyuinone (vitamin K) component in its structure, thus in- 
dicating that these polyisoprenoid lipids are not a major form 
of mannose-accepting lipid in bovine liver in vitro. 
Analysis of the lipid by mass spectrometry after alkaline hy- 
drolysis indicates that the lipid is a polyisoprenoid compound. 
The mass spectrum, illustrated in Fig. 5, reveals a characteristic 
pattern of triads of fragment ions separated by 68 mass units, 
representing random cleavage between individual isoprene units 
in a chain. The prominent peak in each triad has a mass/charge 
value of [(n x 68) + 21, i.e. 2 mass units greater than the equiv- 
alent ions for undecaprenyl lipids isolated from bacterial systems 
(30, 31). The molecular ion was not visible in the mass spectrum 
and, thus, the precise number of isoprene units in the lipid re- 
mains to be established. However, on the basis of its spectral 
characteristics, it was concluded that the lipid was a dihydro- 
polyisoprenol, consisting of at least 18 isoprcne units, one of 
which is saturated. These results suggest that the lipid is a 
form of dolichol (15), a C-100 a-saturated polyisoprenol, which, 
as dolichol monophosphate, has been characterized as a glgcosyl 
acceptor in liver microsomes by Lcloir (16, 32), and Hemming 
(8), and their co-workers. III addition, the chemical and chro- 
matographic properties of the mannolipid are comparable to 
those of synthetic dolichol-monophosphate-mannose prepared ac- 
cording to Behrens, Leloir et al. (16, 32). 
Role oj Mannolipid in Glycosylation of Protein 
Incorporation sf Xannose into Mannolipid and Protein-As 
shown in Figs. 1 and 2 the incorporation of mannose from GDP- 
[14C]mannose into mannolipid reached a plateau after al)proxi- 
mately 5 min of incubation in the presence of less than 10 pM 
GDP-mannosc. The cessat,ion of mannolipid formation could be 
attributed to the total destruction of GDP-mannose in the in- 
cubation mixture within the first 5 min. As illustrated in Fig. 1, 
however, incorporation of mannose into protein continued for at 
least 2 hours, concomitant with a decrease in mannolipid. Dur- 
ing the period from 5 to 120 min, the radioactivity in protein 
increased by approximately 500 cpm, while the decrease in man- 


























FIG. 5. Mass spectrum of bovine “lo, 
liver mannoliuid. Purified manno- Z 1 
lipid (0.5 ELM- organic phosphorus) g : 
was saponified as described under r50~ 
“Experimental Procedure,” and ana- 1 
lyzed by mass spectrometry on an 
11 
/Ill I 
LKB type 9000 mass spectrometer at 
70 e.v. ionization energy, using a di- 
rect probe at 25OO.2 
Thus, these results suggested that the mallnose-contaillirlg lipid 
was serving as a precursor to mannose residues incorporated into 
the protein fraction. 
In these experiments, mannolipid formation accounted for 5 
to 10% of added substrate, and 0.2 to 1 y0 of the [14C]mannose was 
recovered in the protein fraction. In general, the amount of 
[14C]mannose incorporated into protein after 2 hours of incuba- 
tion was directly proportional to the amount of mannolipid orig- 
inally formed in the incubation mixture. In Figs. 6 and 7 this 
dependency of protein mannosylation on lipid formation is also 
observed. Loss of [14C]mannose from the mannolipid, however, is 
generally 2- to 3-fold in excess of the amount required fol mall- 
nosylation of protein. It is apparent that some of the manno- 
lipid is undergoing degradation to produce free mannose or 
mamiose l-phosphate, but another more complex product, in 
addition to protein, is also being formed from the mannolipid; 
this is discussed in more detail in the text discussion of Fig. 8. 
Pulse-chase Kinetics-When the GDP-[Slmannose is chased 
by an excess of nonradioactive substrate at times prior to the 
cessation in mannolipid formation (less than 3 min), the subse- 
quent incorporation of radioactivity into lipid and protein is 
affected differently. As illustrated in Fig. 6, addition of a IOO- 
fold excess of GDl-‘-mannose at 30 s results in an abrupt cessation 
in mannose incorporation into the lipid fraction, with an eventual 
resumption of incorporation at about >iooth the original rate. 
Despite the effective chase in the mannolipid-forming reaction, 
however, incorporation of mannose into protein persists following 
the chase and ultimately reaches a value proportional to the 
amount of mannose incorporated into the mannolipid during the 
30-s pulse, i.e. total incorporation into protein at 60 min is about 
8% of mannolipid formed in each incubation mixture. From 
2 We are indebted to Dr. Iain Campbell of the Mass Spectrom- 
etry Facility, University of Pittsburgh for conducting the mass 
spectral analyses. 
FIG. 6. Pulse-chase kinetics of mannose incorporation into lipid 
and protein. Two separate incubations of 1.0 and 1.3 ml, re- 
spectively, contained 4 PM GDP-mannose (100,000 cpm) with 1.2 
mg of protein per loo-p1 aliquot. To the first incubation 100 ~1 
of 10 rnM GDP-mannose were added as a chase at 30 s, and aliquots 
were withdrawn starting at 1 min. The second incnbation (con- 
trol) had been diluted equivalently with buffer at zero time. 
these results, GDP-mannose appears to be the direct precursor 
for mannose incorporation into the mannolipid, but not into the 
protein fraction. The results are consistent with the previous 
evidence (Fig. 1) that the mannolipid may serve as an intermedi- 
ate in the transfer of mannose from GDl’-mannose to protein. 
Effect of EDTA on Incorporation OJ” Xannose into Lipid and 
Protei?L-Addition of 50 mar EDTA to an incubation at 5 min, 
after mannolipid formation has reached a maximum, has no sig- 
nificant effect either on the subsequent kinetics and cstcnt of 
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FIG. 7. Effect of EDTA on incorporation of mannose into lipid 
and protein. All incubations were conducted at 4 FM GDP- 
mannose (100,000 cpm), and contained 1.2 mg of protein per 100.~1 
aliquot. Aliquots of 0.5 M sodium EDTA, pH 7.0, were added at 
-5 min (preincubation) or at +30 s or +5 min respectively; 
GDP-mannose was added at zero time. Final EDTA concentra- 
tion was 50 mivr. 
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FIG. 8. Direct transfer of mannose from mannolipid to protein. 
A I-ml incubation mixture contained 20 mg of delipidated micro- 
somes and 40,000 cpm of partially purified mannolipid. Aliquots 
(100 ~1) were quenched with 300 ~1 of butanol-pyridinium acetate 
then diluted with 200 ~1 of HZO, and centrifuged. Distinct aque- 
ous and organic phaseswere collected separately; two additional ex- 
tractionswere performed with 300~1 of butanol-pyridinium acetate 
and 200 ~1 of HeO, and the aqueous and organic extracts were 
pooled and counted. The protein fraction was washed and 
counted as described under “Experimental Procedure.” 
ante of mannose from the lipid fraction (Fig. 7, upper two curves 
of each frame). Preincubation with EDTB, or addition of 
EDTA immediately prior to addition of GDP-mannose, however, 
result’s in nearly complete inhibition of mannose incorporation 
into bot’h lipid and protein (Fig. 7, lowest curve of each frame). 
If  EDTA is added at intervals up to 5 min (30 s in Fig. 7), in- 
corporation of mannose into lipid ceases immediately while man- 
nose incorporation into protein continues to an extent approxi- 
mately proportional to the amount of mannolipid formed prior 
to addition of EDTA. Even in the mixture preincubated with 
EDTA, the amount of [‘%]mannose incorporated int’o protein is 
approximately 5 to 10°yO of the mannolipid formed. 
Thus, by the use of EDTA to &elate divalent cations, it is 
possible to show that, of the two mannosyltransferase reactions, 
only the transfer to lipid is dependent on Mn2f or Mg2+. Never- 
theless, the extent of mannose incorporation into protein is indi- 
rectly sensitive to EDTA and is controlled by the extent to which 
mannose is incorporated into lipid. These observations are 
similar to those of Scher and Lennarz (33) on mannan synthesis 
in Micrococcus lysodiekticus, and provide further indirect evidence 
that the mannolipid is an intermediate in the transfer of mannose 
from GDP-mannose to protein. 
Direct Transfer of Mannose from Mannolipid to Protein-All 
attempts to demonstrate the transfer of mannose from exoge- 
nously supplied, crude mannolipid preparations to endogenous 
microsomal protein were unsuccessful. However, delipidation 
of the microsomal preparation by treatment with organic solvents 
and partial purification of the [14C]mannolipid used as substrate 
provided a system that permitted the direct utilization of the 
mannolipid as a mannosyl donor in the glycosylation of endog- 
enous microsomal protein. It was later shown that delipidation 
of the microsomes was not necessary, but that the most critical 
factor was the use of purified [r4C]mannolipid as substrate. This 
purification scheme (see “Experimental Procedure”) degrades 
glycerophospholipids by alkaline methanolysis, and uses batch 
elution from DEAE-cellulose with CHCL-acetic acid (3: 1) to 
remove neutral lipids, fatty acids, and bile salts (23). The man- 
nolipid is then eluted with 9997, CH30H containing 0.2 M NH4Ac. 
The utilization of the purified [14C]mannolipid as substrate for 
the transfer of mannose residues to protein is illustrated in Fig. 
8. In this incubation mixture approximately 15% of the [‘“Cl- 
mannose added as [14C]mannolipid was transferred to protein. 
A larger proportion of the radioactivity was recovered in the 
aqueous phase. When the material in the aqueous phase was 
collected from a second incubation mixture quenched at 60 min 
and chromatographed on a column of Rio-Gel P-2 in H20, 50% 
of the radioactivity eluted as a sharp peak at the exclusion vol- 
ume of the column (exclusion mol wt - 1800). The remainder 
eluted as a second sharp peak at the retention volume, and was 
identified as mannose by electrophoresis in 1 y0 sodium borate. 
When the material at the exclusion volume of the P-2 column 
was rechromatographed on Sephadex G-50 in 0.15 M NaCl, it 
was eluted as a single peak of radioactivity with an apparent 
molecular weight of 2200 (estimated from data in Reference 34). 
This material migrated toward the anode upon electrophoresis 
in Buffer D at pH 1.85, but treatment with alkaline phosphatase 
converted it to a neutral compound, indicating that it was not 
a peptide. The composition, source, and function of this low 
molecular weight compound containing mannose and phosphate 
are currently under study. 
The extent of transfer of mannose from mannolipid to protein 
is dependent on several factors. [14C]Mannolipid in the crude 

























because of contamination by a large excess of other lipids and 
their degradation products. The partial purification obtained 
by alkaline mcthanolysis and DE;1E-cellulose chromatography 
yields an active preparation, and further purification by thin 
layer chromatography after the DEAE-cellulose step results in 
only a slight increase in activity. The advantage of the addi- 
tional purification step, however, is offset by the poor recovery 
of mannolipid from thin layer plates. Delipidation of the mi- 
crosomal protein does not alter the amount of mannose trans- 
ferred from mannolipid to protein during an incubation, but the 
transferase activity is more stable to storage following delipida- 
tion. It is possible that the transferase is sensitive to free fatty 
acids and lysophospholipids released gradually by phospholipases 
in the microsomes. Since the delipidation procedure removes 
greater than 90% of the lipid phosphorus, the formation of 
these inhibitors would be decreased. 
The extent of transfer of mannosc from mannolipid to protein 
is directly proportional to both protein and lipid concentration 
(Fig. 9). The increasing extent of mannolipid utilization for 
transfer to protein with increasing protein concentration (Fig. 
9A) is expected in a reaction dependent on endogenous acceptor. 
The addition of several different proteins (e.g. bovine serum 
albumin, ovalbumin, thgroglobulin, and ribonuclease) to incuba- 
tions results in a nonspecific stimulation of incorporation of 
mannose into endogenous protein acceptors by the tumor micro- 
somes. Despite the fact that ovalbumin has terminal mannose 
and acetylglucosamine residues (35), and thyroglobulin (36) and 
ribonuclease (37) have terminal mannosc residues, there is no 
indication, by gel chromatography of the mannose-containing 
protein products of an incubation, that an>- of these proteins 
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FIG. !I. I<ffect of protein (A) and lipid (B) concentration on 
transfer of mannose from mannolipid to protein. Standard 
300-J incubation mixtures contained increasing aliauots of de- 
lipidated protein (A) or partially purified marm&pid*(B). In A, 
incubations contained 10,000 cpm of lipid. In B, incubations 
contained 10 mg of prot.ein. Separate zero time blanks were run 
for each incubation. The yield of [lVZ]mannose-labeled protein 
Xannolipid as Direct Donor OJ SIannose to ProteirL-Ricshards 
and Hemming (8) have reported that incubation of [14C]man- 
nolipid with pig liver microsomcs results in the formation of 
GDP-[Wlmannosc, presumably by reaction of the mannolipid 
with endogenous GDP in the microsomal prcparatiom.. ‘l’llLlS, 
was measured at 45 min. it is conceivable that the mannolipid is functioning as a stable 
3701 
or mannolipid. While there is evidence that yeast mannans 
are synthesized from GDP-mannose by way of a mannolipid 
intermediate (38, 39), addition of yeast mannan to incubation 
mixtures had no effect on the tumor system. 
The fact that addition of greater amounts of exogenous lipid 
to an incubation results in an increased yield of [‘4C]mannosc- 
labeled protein (Fig. 9B) probably indicates increased activity 
of the labile transferase at increasing, but subsaturating, levels 
of the mannolipid substrate. These observations are consistent 
with similar experiments using fresh microsomes with GDP- 
mannose as substrate where the extent of mannose incorporation 
into protein is also linearly dependent on both the l)rotcin con- 
centration (data not shown) and the amount of mannolipid 
generated endogenously from GDP-mannose (Figs. 6 and 7) 
Effect oj Organic Solvent Extraction of .Microsomes-Butanol or 
acetone (31) extraction of microsomes caauses a 40 to 607; de- 
crease in the amount of [14C]mannolipid formed from GDP- 
mannose per mg of protein in an incubation mixture. There is 
also a proportional decrease in the amount of mannose trails- 
ferred from GDP-mannose to protein. The activities for transfei 
of mannose to lipid and protein are not sensitive to the organic 
solvent extractions, however, since both activities can bc re- 
stored to their original levels by supplementing the incubation 
mixtures with aliquots of the organic solvent extract. The 
restoration of activity is dependent on an acidic lipid fraction 
(based on DEAE-cellulose chromatography) which is stable to 
mild alkaline methanolysis. The active lipid is presumably the 
mannose acceptor lipid, dihydropolyisoprenol monophosphate. 
The simultaneous stimulation of mannose transfer from GDP- 
mannose to both lipid and protein is consistent with its proposed 
role as a glycosyl carrier lipid. Richards and Hemming (8) 
have also reported the stimulatory effect of polyisoprenol phos- 
phates on transfer of mannosc from GDP-mannose to both lipid 
and protein in liver microsomal preparations. 
Relative Eficiency OJ” Endogenous and Exogenous Mannolipid 
as Jlannose Donor to Protein-The observation that crudr micro- 
somes could transfer mannose from mannolipid to protein pro- 
vided a means to test quantitatively the precursor-product rela- 
tionship between mannolipid and mannosylated protein. Thus, 
regardless of whether GDP-[‘*Cl mannose is used as the original 
substrate to generate [W]mannolipid in s&l, or a similar amount 
of [14C]mannolipid is supplied esogcnously, the same amount of 
[W]mannose should be incorporated into protein. The results 
shown in Table II establish that crude microsomes utilize tither 
endogenously generated (from GDP-mannose) or esogrnously 
supplied mannolipid with equal efficiency for transfer of mannose 
to protein. In both Experiments A and I{ the percentage of 
transfer of mannose from endogenously generated mannolipid 
to protein is comparable to the percent.age of transfer from esog- 
enously supplied lipid. The presence of the large excrssc~ of 
GDP-mannose (200,000 to 360,000 epm) in the experiments 
generating endogenous mai~i~olipicl results in no mannosc ill- 
corporation into protein beyond that which can be accounted fol 
by the lipid alone. Thus, the role of GDP-mannosc as a direct 
and immediate donor of mannose residues to protein npl)cars to 
be insignificant in the mycloma microsomal system. Similar 


























reservoir of activated mannose residues, gradually generating 
GDP-mannose to serve as the actual donor of mannose to pro- 
tein during the incubation. The results in Table III describe a 
direct experiment to verify the role of mannolipid as the im- 
mediate donor of mannose to protein. 
Thus, in the presence of 50 mM EDTA, transfer of mannose 
from GDP-mannose to both lipid and protein is greatly inhibited 
(Table III, compare first two lines of each experiment). Less 
than 0.050/, of the mannose is transferred to protein in either 
experiment in the presence of EDTA. Under the same condi- 
tions, however, exogenously added mannolipid functions as a 
relatively efficient donor of mannose to protein (Table III, last 
line of each experiment). About 2% of the mannose radio- 
TABLE II 
Relative eficiency of endogenously formed versus exogenously 
added mannolipid as substrate for transfer of 
mannose to protein 
Each incubation contained 5 mM MgClz, 5 mM MnC12, 0.5yo 
Triton X-100, and 3 mg of protein in a total volume of 200 ~1. 
Experiments A and B were performed using separate preparations 
of both protein and lipid. The mannolipid counts per min value 
in parentheses (incubations using GDP-mannose as substrate) 
is the amount of mannolipid formed from the GDP-mannose at 
























ransfer of lipid 
to protein 
Effect of EDTA on mannose transfer to protein from 
GDP-mannose and mannolipid 
Each incubation mixture contained 0.5% Triton X-100 and 3 
mg of protein in a final volume of 200 pl. Either 5 mM MgCls and 
5 mM MnCls (MS+), or 50 mM sodium EDTA, pH 7.4 were added, 
as indicated. Experiments A and B were performed with differ- 
ent protein preparations. Reactions were quenched at 45 min 
for determination of mannose incorporated into protein. The 
mannolipid counts per min value in parentheses (incubations 
with GDP-mannose as substrate) is the amount of mannolipid 
determined at the 45-min time point. Percentage of transfer to 
protein is based on amount of added substrate; values in paren- 









































activity is transferred from mannolipid to protein, and about 
80% is recovered unchanged from the incubation. Even if all 
of the exogenously added mannolipid substrate were converted 
to GDP-mannose in these incubations, this amount of GDP- 
mannose would be inadequate to account for the protein product 
because of the low efficiency (0.05%) of transfer from GDP- 
mannose in the presence of EDTA. Thus, the mannolipid must 
be serving as the direct donor of mannose residues to protein and 
as a true intermediate in the mannosylation of glycoprotein by 
GDP-mannose. 
A 40 to 50% inhibition of mannose transfer from lipid to pro- 
tein is observed in the presence of EDTA (Table III, compare 
last two lines of each experiment). The reason for the effect is 
not clear, but it may result from differential solubility or an 
altered state of the mannolipid in incubation mixtures in the 
absence of divalent cation. This effect of EDTA is not observed 
in the absence of Triton X-100 (cf. Fig. 7) where the lipid is 
presumably firmly fixed in the microsomal membrane structure. 
Characterization of Protein Products 
Gel Chromatography-Since fresh microsomes could use either 
GDP-mannose or mannolipid for mannose transfer to protein, 
the protein products formed from the two substrates could be 
compared. The radioactivity profiles of the sodium dodecyl 
sulfate-solubilized protein products on Sephadex G-150 (Fig. 
10A) indicate that both GDP-mannose and mannolipid are trans- 
ferring mannose to the same endogenous protein acceptor(s) 
in the myeloma tumor microsomes. In addition, the majority 
of the radioactivity elutes in a peak which has the same elution 
volume as authentic K-46, the predominant species of glyco- 
protein in the MOPC-46B cell. This elution pattern is different 
from that obtained with microsomes of the host mouse liver (Fig. 
10B) which synthesizes a whole spectrum of proteins for secre- 
tion. Even in the liver, however, there is an essential identity 
between the radioactivity profiles of protein labeled from either 
GDP-mannose or mannolipid. 
Proteolytic Digestion-Confirmation that mannose-labeled 
product which was precipitable by organic solvent (butanol- 
pyridinium acetate), 10% trichloroacetic acid and 80% ethanol, 
was, in fact, a glycoprotein was obtained by demonstrating its 
conversion to low molecular weight material upon incubation 
with proteolytic enzymes (Fig. IOC). Control incubations 
without proteolytic enzymes showed less than 5% conversion to 
low molecular weight products, while proteolysis normally re- 
sulted in 50 to 100% conversion with an average value of about 
70%. Proteolysis was performed in 5 M urea, and both Pronase 
and subtilisin were required for efficient digestion. The protein 
products had been thoroughly denatured and aggregated by 
precipitation and extraction with organic solvent, trichloroacetic 
acid, and ethanol, and were not readily digestible under milder 
conditions of proteolysis. The undenatured mannose-containing 
protein in the incubation mixtures, however, was greater than 
80% digestible by Pronase, subtilisin, trypsin, or pepsin but not 
by hyaluronidase or P-amylase, as determined by the decrease 
in butanol-pyridinium acetate and trichloroacetic acid-precipi- 
table radioactivity at the end of 4 hours. 
The low molecular weight products of the proteolytic digestion 
were subjected to electrophoresis under acidic (Buffer D) and 
basic (Buffer E) conditions (Fig. ll), and were shown to be 
zwitterionic, behaving as cations at pH 1.9 and anions at pH 8.7, 
consistent with their characterization as glycopeptides. Within 
the limits of resolution of the electrophoresis, the glycopeptides 
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FIG. 10. Sephadex G-150 profiles of sodium dodecyl sulfate-solu- 
bilked protein from incubations using GDP-mannose (X- - -X) 
or mannolipid (O--O) substrates. Protein recovered from 
incltbations was solubilixed in 2.5y0 sodium dodecyl sulfate, 1% 
mercaptoethanol, 0.1 M EDTA, 0.05 M sodium phosphate, pH 8.0, 
applied to a cohlmn (1 X 40 cm) of Sephadex G-150, and eluted 
n-ith the same buffer containing 1% sodium dodecyl sulfate. A, 
mannose-containing protein from incubations with mouse mye- 
loma microsomes. The position of [3H]leucine-labeled K-46, pre- 
pared according to Melchers et al. (40), is shown at one-tenth 
scale. H, mannose-containing protein from incubations with 
mouse liver. C’, tumor protein after proteolysis by Pronase and 
subtilisin (see “P:xperimental Procedure”). Glycopeptides were 
pooled (Fractions 35 to 47) for electrophoresis shown in Fig. 11. 
Final yields were 12,900 cpm of peptide from 17,850 cpm of protein 
from GDP-manuose (73y0 recovery), and 7000 cpm of peptide 
from 11,700 cpm of protein from mannolipid (60% recovery). 
ing acid hydrolysis of separate preparations of glycoprotein it 
was shown that all of the radioactivit’y co-chromxtographed with 
a rnannose standard on paper chromatography in Solvent System 
13. 
The results ol’ the present study clearly establish that a dihy- 
dropolyisoprenol phosphate functions as a glycosyl carrier lipid 
in mammalian systems, mediating tExe transfer of mannose from 
GDP~mannose to protekn. The experiments described in Table 
I II establish that the mannolipid can function as a direct donor 
of mannose rrsidues to protein. It is clear that mannolipid is 
not forming GDP-mannose i?z situ to serve as the glycosyl donor 
silw, in the presence of EDTA, GDP-mannose is ineffective in 
the glycosylatiorr of protein. Three independent experimental 
approache? using GDP-[W]mannose as initial substrate confirm 
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FIG. 11. Electrophoresis of glycopeptides. The mannose 
containing protein from incubations of myeloma trlmor micro- 
somes with either GDP-mannose or mannolipid were digested 
with Pronase and subtilisin and were processed as described lmder 
“Experimental Procedure.” Electrophoresis was performed for 
2 hours at, 2500 volts. An unlabeled mannose standard was in- 
cluded in each sample to measure the migration of neutral com- 
polmds in the electroendosmotic flow of buffer. 
GDP-mannose had been completely degraded in the incubation 
mixture (Fig. l), incorporation of mannose into protein con- 
tinued concomitant with a loss of radioactivity from the lipid 
fraction. (b) When GDI’~[14C]mannosc was chased with a large 
excess of nonradioactive substrate, incorporation of [Wlmannose 
into protein continued normally (Fig. 6) to an extent propor- 
tional to the amount of [14C]mannolipid formed prior to t,hc 
chase. (c) As shown in Fig. 7, EDTA inhibits transfer of man- 
nose to both lipid and protein when added at zero time, while 
addition at later times during the incubation resulted only in a 
cessation of mamiolipid formation. Iircorporalion into protein 
continued aft,erwards to au extent proportional to the amount of 
mannolipid formed prior to addition of EDTA. 
In experiments with the microsomal preparation from mycloma 
tumors, it appears that the rnannolipid is an essential intermedi- 
at,c in mannose transfer to protein. When microsomes were 
incubated with either GDP-mannosc or mannolipid as substrate, 
the gel fikration profiles of the protein products are qualitatively 
similar (Fig. 10). Electrophorctic comparison of the peptides 
produced by proteolysis of the protein products from either sub- 
strate, GDP-mannose or mannolipid (Fig. II), also supports the 
contention that both substrates arc glycosylating the same or 
similar proteins. Moreover, it is clear from the results in Table 
II that the amount of mannose transferred to protein is quantita- 
tively proportional to the amount of mannolipid available, 
regardless of whether the mannolipid was generated endogenously 
from GDP-mannose or added esogenously. 
The mannosylated protein formed in tumor microsomes from 
either GDP-mannose or mannolipid fractionates on Sephades 


























position as authentic K-46 (Fig. lOA). Further studies are in 8. RIcr-~.\it~s, J. B., AND HI:.\~MIX~, F. W. (1972) I?ioche~~~. J. 130, 
progress to determine whether the acceptor protein is, in fact, 77 
related to the sgnthcsis of K-46, the major natural glycoprotein 9. MIGLCHERS, F. (1969) Biochemistry 8, 938 
product of the myeloma tumor in VT&J. It can bc seen, hoIT-ever, 
10. MELCHERS, F., AND KA-OPF, P. M. (1968) Coltl Spri?i(l Harbor 
Symp. &uant. Biol. 32, 255 
that the mannosylated proteins formed in mouse liver micro- 11. CHOI, Y. S,, KNOI’F, P. ill., .\SII LICXSOX, IX. S. (1971) Rio- 
somes are different from those observed in the tumor system, chemistry 10, 668 
suggesting that there is a characteristic class of protrins gl\-cosyl- 12. MI<SLCHEIG, F. (1970) Biochem. J. 119, 765 
ated in each cell type. 
13. ROTHFIELD, L., AND ROMISO, 1~. (1971) Bacterial. Rw. 35, 14 
Only a single species of polyisoprenoid mannolipid II-as de- 
14. LI:NN.\KZ, W. J., AND &HER, AI. G. (1972) Biochim. Riophys. 
Acta 265, 417 
tected in bovine and mouse liver and in the mouse myeloma 
tumor. The ultraviolct and visible spectra of the purified man- 
nolipid provided no evidence of a conjugated carotenoid (vita- 
min A), chromanr (vitamin E), or ubiquillonc (vitamin K) struc- 
ture, nor did the mass spectrum of the lipid at probe temperatures 
below 250” revcal fragmentation patterns attributable to these 
polyisoprenoid vitamins. These results do not exclude the 
possibilities that: (a) vitamiu A (41-43)) E, or K (44) derivatives 
may serve as mannose acceptors in vitro; (b) they may function as 
glycosyl carrier lipids in other cell Qpes; or (c) these vitamins 
ma)- be converted in vivo to a lipid which serves as a mannose 
acceptor. It appears, liowewr, that the endogenous glycosyl 
carrier lipid participating in transfer of mannosc to protein in the 
liver and myeloma tumor is a long chain dihydropolyisoprellol 
phosphate. It is not yet clear whether the same lipid or distinct 
members of a family of isoprcnoid lipids function as carriers for 
different sugars, but there is strong evidence indicating that both 
glucose (16, 32, 45) and A-acetylglucosamine (46-48) are trans- 
ferred to protein through glycolipid intermediates. 
In bacterial systems the underaprenyl lipids function in the 
cell enr-elope as glycosyl carrier lipids, intermediate in the 
biosynthesis and polymerization of con~l&x carbohydrate-con- 
taining macromolecules (13, 14, 27, 30, 31, 33). Thilc there is 
no direct evidence, a similar mechanism may also be operative 
in mammalian systems for the synthesis of the core region of the 
oligosaccharide side chain of plasma glycoproteins. 1101x-ever, 
in the myeloma system we were unable to dctcct any species 
of lipid which contained more than a single mannose residue or 
both mannose and A’-acetylglucosamine residues, as might be 
espwted if the core oligosaccharide were first constructed on a 
lipid backbone, prior to transfer to protein. But the low molecu- 
lar weight (-2200) compound containing mannose and phos- 
phate, a major product formed when mannolipid is incubated 
with tumor microsomcs, may be a degradation product of such a 
lipid. I f  this is the case, then the polyisoprenoid mannolipid 
dcscribcd in this study may not be the only glycolipid illtermedi- 
ate in\-olved in the transfer of mannose from GDP-mannose to 
protein. 
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